相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer
Yu Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
Candace J. Poole et al.
EPIGENETICS & CHROMATIN (2019)
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
Salma Parvin et al.
CANCER CELL (2019)
TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells
Nipun Verma et al.
NATURE GENETICS (2018)
Distinct chromatin signatures of DNA hypomethylation in aging and cancer
Raul F. Perez et al.
AGING CELL (2018)
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
M. Catherine Pietanza et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
Jinghan Wang et al.
EBIOMEDICINE (2018)
DNA Damage, Repair, and Cancer Metabolism
Marc-Olivier Turgeon et al.
FRONTIERS IN ONCOLOGY (2018)
TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells
Ageliki Tsagaratou et al.
NATURE IMMUNOLOGY (2017)
TET1 modulates H4K16 acetylation by controlling auto-acetylation of hMOF to affect gene regulation and DNA repair function
Jianing Zhong et al.
NUCLEIC ACIDS RESEARCH (2017)
TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agents
Jonathan B. Coulter et al.
EPIGENETICS (2017)
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Yu Liu et al.
NATURE GENETICS (2017)
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma
V. Colicchia et al.
ONCOGENE (2017)
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
Xi Jiang et al.
NATURE COMMUNICATIONS (2017)
TET Methylcytosine Oxidases in T Cell and B Cell Development and Function
Ageliki Tsagaratou et al.
FRONTIERS IN IMMUNOLOGY (2017)
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition
Elena Sanmartin et al.
CLINICAL CANCER RESEARCH (2017)
TET3-mediated DNA oxidation promotes ATR-dependent DNA damage response
Dewei Jiang et al.
EMBO REPORTS (2017)
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
Donna L. Nile et al.
BMC CANCER (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Control of Foxp3 stability through modulation of TET activity
Xiaojing Yue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Biochemical reconstitution of TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated mechanism
Alain R. Weber et al.
NATURE COMMUNICATIONS (2016)
5-Hydroxymethylcytosine Marks Sites of DNA Damage and Promotes Genome Stability
Georgia Rose Kafer et al.
CELL REPORTS (2016)
5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4+ T Cells
Colm E. Nestor et al.
CELL REPORTS (2016)
Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs
Jiao Yang et al.
CELL REPORTS (2016)
Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
Vincenzo Giambra et al.
BLOOD (2015)
Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis
Min-Zu Wu et al.
CANCER RESEARCH (2015)
TET1 is a tumor suppressor of hematopoietic malignancy
Luisa Cimmino et al.
NATURE IMMUNOLOGY (2015)
Acute loss of TET function results in aggressive myeloid cancer in mice
Jungeun An et al.
NATURE COMMUNICATIONS (2015)
5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme
Fabio Ciccarone et al.
ONCOTARGET (2015)
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
Zhigang Zhao et al.
CELL REPORTS (2015)
DNA repair mechanisms in cancer development and therapy
Alessandro Torgovnick et al.
FRONTIERS IN GENETICS (2015)
Epigenetics in T-cell acute lymphoblastic leukemia
Sofie Peirs et al.
IMMUNOLOGICAL REVIEWS (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
Global DNA hypomethylation in prostate cancer development and progression: a systematic review
R. Zelic et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies
Melinda G. Hollingshead et al.
BMC GENOMICS (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells
Stephen J. Roper et al.
NUCLEIC ACIDS RESEARCH (2014)
Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription
Fabio Ciccarone et al.
ONCOTARGET (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
TET1 plays an essential oncogenic role in MLL-rearranged leukemia
Hao Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dynamics of 5-Hydroxymethylcytosine and Chromatin Marks in Mammalian Neurogenesis
Maria A. Hahn et al.
CELL REPORTS (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways
Lueder Hinrich Meyer et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development
Meelad M. Dawlaty et al.
CELL STEM CELL (2011)
Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells
Hao Wu et al.
GENES & DEVELOPMENT (2011)
Genome-wide Regulation of 5hmC, 5mC, and Gene Expression by Tet1 Hydroxylase in Mouse Embryonic Stem Cells
Yufei Xu et al.
MOLECULAR CELL (2011)
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C. Evangelisti et al.
LEUKEMIA (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
Shinsuke Ito et al.
NATURE (2010)
γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin
Christophe E. Redon et al.
ADVANCES IN SPACE RESEARCH (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Adult T-cell acute lymphoblastic leukemia:: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol
A Vitale et al.
BLOOD (2006)
Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines
JP Banáth et al.
CANCER RESEARCH (2004)
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)
RB Lorsbach et al.
LEUKEMIA (2003)
分享论文
